RecallRadar

FDA Drug recall D-0895-2023

Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limite…

On 2023-07-12 the FDA classified a Class II recall of Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limite… by Strides Pharma, citing presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0895-2023
ClassificationClass II
Statusterminated
Initiated2023-06-26
Published2023-07-12
Last updated2026-09-13 11:52 UTC
CompanyStrides Pharma
DistributionUS

Product

Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08

Reason

Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.

Identifiers

ndc64380-933-04
ndc64380-933-05
ndc64380-933-08
ndc64380-934-04
ndc64380-934-05
ndc64380-934-08
ndc64380-935-04
ndc64380-935-05
ndc64380-935-08
code_infoLot#: 7901903A, exp. date 04/2024

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0895-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.